当前位置:首页 - 行情中心 - 贝瑞基因(000710) - 财务分析 - 现金流量表

贝瑞基因

(000710)

  

流通市值:46.83亿  总市值:50.24亿
流通股本:3.30亿   总股本:3.54亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金485,524,295.91236,129,690.91,150,398,015.72821,350,091.16
  收到的税费返还3,388,626.123,387,678.09350,641.8263,250.06
  收到其他与经营活动有关的现金2,872,499.61,638,468.755,795,003.693,356,295.02
  经营活动现金流入小计491,785,421.63241,155,837.741,156,543,661.23824,769,636.24
  购买商品、接受劳务支付的现金274,648,805.43148,595,050.59520,349,424.37375,116,516.05
  支付给职工以及为职工支付的现金163,134,578.2779,254,113.66322,893,191.11243,297,014.96
  支付的各项税费20,631,683.157,955,587.7863,934,945.1553,753,798.64
  支付其他与经营活动有关的现金65,272,787.0139,944,476.97161,396,178.89129,699,560.25
  经营活动现金流出小计523,687,853.86275,749,2291,068,573,739.52801,866,889.9
  经营活动产生的现金流量净额-31,902,432.23-34,593,391.2687,969,921.7122,902,746.34
二、投资活动产生的现金流量:
  收回投资收到的现金9,502,364.16---
  处置固定资产、无形资产和其他长期资产收回的现金净额2,226,3002,222,300421,040,811.45309,503,280
  收到的其他与投资活动有关的现金--12,344,515.56-
  投资活动现金流入小计11,728,664.162,222,300433,385,327.01309,503,280
  购建固定资产、无形资产和其他长期资产支付的现金36,941,835.412,560,779.9756,754,406.1435,334,503.11
  投资支付的现金2,222,2002,222,200171,500,000171,500,000
  支付其他与投资活动有关的现金--14,700,00040,800,468.55
  投资活动现金流出小计39,164,035.414,782,979.97242,954,406.14247,634,971.66
  投资活动产生的现金流量净额-27,435,371.24-12,560,679.97190,430,920.8761,868,308.34
三、筹资活动产生的现金流量:
  取得借款收到的现金149,260,233.4326,700,000123,296,255.68116,996,255.68
  收到其他与筹资活动有关的现金--1,086,400-
  筹资活动现金流入小计149,260,233.4326,700,000124,382,655.68116,996,255.68
  偿还债务支付的现金99,996,255.6815,020,684.35296,793,968.69296,793,968.69
  分配股利、利润或偿付利息支付的现金2,120,005.721,002,932.718,692,207.517,714,042.66
  支付其他与筹资活动有关的现金4,986,669.64-56,744,561.6411,002,403.17
  筹资活动现金流出小计107,102,931.0416,023,617.06362,230,737.84315,510,414.52
  筹资活动产生的现金流量净额42,157,302.3910,676,382.94-237,848,082.16-198,514,158.84
四、汇率变动对现金及现金等价物的影响-2,104,346.99-505,136.481,631,167.18-842,255.14
五、现金及现金等价物净增加额-19,284,848.07-36,982,824.7742,183,927.6-114,585,359.3
  加:期初现金及现金等价物余额358,312,814.14358,312,814.14316,128,886.54316,128,886.54
  期末现金及现金等价物余额339,027,966.07321,329,989.37358,312,814.14201,543,527.24
补充资料:
  净利润-25,410,162.78--188,175,034.28-
  资产减值准备--28,078,288.63-
  固定资产和投资性房地产折旧31,805,648.17-74,182,104.23-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧31,805,648.17-74,182,104.23-
  无形资产摊销2,144,195.36-3,008,323.22-
  长期待摊费用摊销5,559,091.7-8,359,791.23-
  处置固定资产、无形资产和其他长期资产的损失11,541.91--1,739,687.32-
  固定资产报废损失142,109.7-500,043.53-
  公允价值变动损失-2,203,689.24-132,165.22-
  财务费用5,513,610-10,403,903.76-
  投资损失-3,257,567.49-14,553,527.69-
  递延所得税-645,625.53-5,326,667.64-
  其中:递延所得税资产减少-1,596,055.68-7,197,424.69-
    递延所得税负债增加950,430.15--1,870,757.05-
  存货的减少2,078,244.8-31,951,607.53-
  经营性应收项目的减少52,344,486.74--16,688,541.53-
  经营性应付项目的增加-125,769,315.32--30,297,511.01-
  其他--633,871.22-
  现金的期末余额339,027,966.07-358,312,814.14-
  减:现金的期初余额358,312,814.14-316,128,886.54-
  现金及现金等价物的净增加额-19,284,848.07-42,183,927.6-
公告日期2025-08-302025-04-282025-04-252024-10-29
审计意见(境内)标准无保留意见
TOP↑